about
sameAs
The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patientsBilirubin and glutathione have complementary antioxidant and cytoprotective rolesInherited disorders of bilirubin clearanceUnconjugated Bilirubin exerts Pro-Apoptotic Effect on Platelets via p38-MAPK activationA humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidationGilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.Genetic influences on serum bilirubin in American Indians: The Strong Heart Family StudyAre liver function tests, pancreatitis and cholecystitis predictors of common bile duct stones? Results of a prospective, population-based, cohort study of 1171 patients undergoing cholecystectomyGlucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10Pharmacogenomics: bench to bedside.Quantification of Hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of UDP glucuronosyltransferase 1A1 variant expression with glucuronidation activityFulminant liver failure associated with delayed identification of thyroid storm due to heterophile antibodies.Pharmacogenetics/genomics and personalized medicine.Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs.Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert's syndrome marker UGT1A1*28.A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome.Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based reviewUGT1A1 gene polymorphism: impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer.The Association between Prolonged Jaundice and UGT1A1 Gene Polymorphism (G71R) in Gilbert's Syndrome.Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potential.UGT1A1*28 relationship with abnormal total bilirubin levels in chronic hepatitis C patients: Outcomes from a case-control study.Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.Nuclear receptors and endobiotics glucuronidation: the good, the bad, and the UGT.Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insights.Liver support strategies: cutting-edge technologies.Effects of serum bilirubin on atherosclerotic processes.Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic DefectsThe molecular basis of jaundice: An old symptom revisited.Case-controlled study on indirect hyperbilirubinemia in exclusively breast fed neonates and mutations of the bilirubin Uridine Diphosphate-Glucuronyl transferase gene 1A1.Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I.Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening.Promoterless gene targeting without nucleases rescues lethality of a Crigler-Najjar syndrome mouse model.Allogeneic hematopoietic stem cell transplantation for acute leukemia with Gilbert's syndrome.In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV.Gilbert syndrome in Iran, Fars Province.Risk factors associated with unconjugated neonatal hyperbilirubinemia in Malaysian neonates.A genome-wide search for non-UGT1A1 markers associated with unconjugated bilirubin level reveals significant association with a polymorphic marker near a gene of the nucleoporin family.Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome.Polymorphisms of the uridine-diphosphoglucuronosyltransferase 1A1 gene and coronary artery disease.
P2860
Q21559550-6653A209-A5D9-4E53-AD4E-DE89382AE56BQ24649034-C9189B38-1E77-40AF-B4F9-69CC3888327AQ26776470-EBEFCF15-81CF-41B6-8CDA-5FA8285076C3Q33426652-ADD1192C-98E7-4D3D-AD4A-3698B07120BCQ33861874-E878659B-FB68-456C-AAA2-EB41EFD3BDEBQ33867195-8C058D65-4C38-42B0-895E-5298644A635CQ34207748-568BEA1E-AD9D-47F8-9FD2-DE7B1F855E5EQ34614162-847E5E1A-FE27-463C-B476-657749DB7B68Q35185186-0F1590E0-B28D-4DE9-9219-79632D68841FQ35745226-95C23385-C908-4066-864B-64453C43859BQ35876017-D682175D-CC82-4E46-9814-13BF9F1A6FABQ36174174-E404DC62-BF73-4133-9E68-AB68D1F60198Q36175760-A49E00AA-48E3-41EA-A0A4-E16F215A009DQ36294685-0A7A93AC-9858-463F-98E0-F61F8795595AQ36795136-402B9683-BBEB-4054-8925-D6E6FE6E42E3Q36944278-700CBAFF-55B4-46F7-AF88-B26F2B4AF856Q37313599-89F32196-6FE0-4E21-ADB5-4B2664683704Q37345974-F78AFA08-63A1-43A7-8DE2-98811206491EQ37402459-C2461B06-4215-4C5B-8FE0-C175854410FDQ37543041-7309A0F3-C488-4DEC-B8CD-30E816EA86FCQ37615354-2ABF2000-974D-450F-97A7-FBCC6C1ED24DQ37725310-820F5C12-FF26-465B-84E6-FC6BDE0165D4Q37990054-35320372-1F9D-4E40-8914-CD31BBB69D34Q38074990-C300B8B9-AD27-47B5-B010-22A7599BD1DCQ38086603-261988A9-11C3-4900-AE5C-C72B0C5E67DFQ38156043-40B0B023-D006-4F62-8951-844657708A37Q38203611-7BCA3F56-3665-46B0-A46B-EE3DFC9C5411Q38849210-6002501D-62FB-4357-B510-AD5D0C8149F3Q39048488-3376A3C6-64C4-4093-AD74-ED315C9ABFEAQ39549524-851E6E62-A181-4973-BA23-203A78BC5A2EQ40084021-3618EF2E-B6E2-4169-ACCF-374E182701E4Q41099201-9FEF2143-DDD2-41C1-82B3-02C18E3F3EC3Q41876346-465958D0-11C5-4E3C-B8AA-822B9ECDF1D9Q42149551-C46880D1-8DC9-424B-9295-8C44605D4822Q42252510-7F77010B-24C6-4D0E-BEB4-BF521CCDC28DQ42848890-05BC75B9-0AF4-4C6F-AFEF-26C94A66A624Q43529994-9F613A8B-7A8B-4093-A8E1-A5C960C7A6D7Q44767175-C867522D-839B-42B4-BE17-ADD3E7FE5A9FQ46036068-3948593C-E89D-46FB-9894-56218A5FA4C7Q46938510-2AEB8EEE-F57F-48A1-A419-180A7F1E6776
P2860
description
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Jahr 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2003)
@en
vedecký článok (publikovaný 2003-01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd in 2003-01)
@nl
наукова стаття, опублікована в січні 2003
@uk
مقالة علمية (نشرت عام 2003)
@ar
name
Inherited disorders of bilirubin metabolism
@ast
Inherited disorders of bilirubin metabolism
@en
Inherited disorders of bilirubin metabolism
@nl
type
label
Inherited disorders of bilirubin metabolism
@ast
Inherited disorders of bilirubin metabolism
@en
Inherited disorders of bilirubin metabolism
@nl
prefLabel
Inherited disorders of bilirubin metabolism
@ast
Inherited disorders of bilirubin metabolism
@en
Inherited disorders of bilirubin metabolism
@nl
P3181
P1476
Inherited disorders of bilirubin metabolism
@en
P2093
Piter Jabik Bosma
P304
P3181
P356
10.1016/S0168-8278(02)00359-8
P407
P577
2003-01-01T00:00:00Z